Mayne Pharma Group Limited
MAYNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$68 | -$26 | -$104 | -$71 |
| Dep. & Amort. | $38 | $34 | $34 | $37 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $2 | $2 | $3 |
| Change in WC | $21 | $21 | $30 | -$20 |
| Other Non-Cash | $37 | -$45 | $51 | $22 |
| Operating Cash Flow | $30 | -$13 | $13 | -$25 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$7 | -$5 | -$16 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | -$5 | $92 |
| Other Inv. Act. | -$18 | -$38 | -$4 | -$8 |
| Investing Cash Flow | -$23 | -$45 | -$14 | $67 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$2 | $0 | -$2 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$0 | $0 | -$11 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $2 | $0 | -$16 |
| Financing Cash Flow | -$0 | -$0 | $0 | -$24 |
| Forex Effect | -$1 | $2 | $1 | -$2 |
| Net Chg. in Cash | -$54 | $54 | -$109 | $8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $54 | $0 | $109 | $102 |
| End Cash | $0 | $54 | $112 | $109 |
| Free Cash Flow | $25 | -$20 | $9 | -$41 |